Numerical detection, measuring and analysis of differential interferon resistance for individual HCV intra-host variants and its influence on the therapy response

In Silico Biology

Volumn 11, Issue 5, 2012, Pages 263-269

  Skums, Pavel ^a   Campo, David S ^a   Dimitrova, Zoya ^a   Vaughan, Gilberto ^a   Lau, Daryl T ^b   Khudyakov, Yury ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

HCV; interferon resistance; Quasispecies

Indexed keywords

ANTIVIRUS AGENT; INTERFERON;

ALGORITHM; ANTIVIRAL RESISTANCE; ARTICLE; DRUG EFFECT; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; THEORETICAL MODEL; VIROLOGY;

ALGORITHMS; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; MODELS, THEORETICAL;

EID: 84872466547     PISSN: 14343207     EISSN: None     Source Type: Journal    
DOI: 10.3233/ISB-2012-0460     Document Type: Article

References (14)

1. M. Alter, "Epidemiology of hepatitis C virus infection", World J Gastroenterol, vol. 13, no. 17, 2007, pp. 2436-2441. (Pubitemid 46929498)
2. E. Domingo, "Biological significance of viral quasispecies", Viral Hepatitis Rev. 2, 1996, pp. 247-261.
3. R. Edgar, "MUSCLE: multiple sequence alignment with high accuracy and high throughput", Nucleic Acids Res., 32(5), 2004, pp. 1792-1797. (Pubitemid 38832724)
4. M. Eigen, J. McCaskill and P. Schuster, "The molecular quasi-species", Advances in Chemical Physics 75, 1989, pp. 149-263.
5. J. Heathcote and J. Main, "Treatment of hepatitis C", J. Viral Hepat, vol. 12, no. 3, 2005, pp. 223-235. (Pubitemid 40638030)
6. M. Isaguliants, "Hepatitis C virus clearance: the enigma of failure despite an impeccable survival strategy", Curr Pharm Biotechnol, vol. 4, no. 3, 2003, pp. 169-183. (Pubitemid 36665401)
7. J. Lara, G. Xia, M. Purdy, Y. Khudyakov. "Coevolution of the hepatitis C virus polyprotein sites in patients on combined pegylated interferon and ribavirin therapy", J. Virol., 85(7), 2011, pp. 3649-3663.
8. F. Lopez-Labrador, et al., "Genetic variability of hepatitis C virus NS3 protein in human leukocyte antigen-A2 liver transplant recipients with recurrent hepatitis C", Liver Transpl, vol. 10, no. 2, 2004, pp. 217-227. (Pubitemid 38240120)
9. M. Novak, "Evolutionary dynamics", Belknap Press of Harvard University Press, 2006.
10. E. Paulon, N.V. Naoumov, "Individualization of antiviral treatment regimens for chronic hepatitis C", European Journal of Gastroenterology and Hepatology, vol. 18, N. 4, 2006, pp. 321-326.
11. J.M. Pawlotsky, "Molecular diagnosis of viral hepatitis", Gastroenterology, 122(6), 2002, pp. 1554-1568.
12. S. Ramachandran, G.L. Xia, L.M. Ganova-Raeva, O.V. Nainan, Y. Khudyakov. "End point limiting dilution real time PCR assay for evaluation of HCV quasispecies in serum", J. Virol Meth, 151(2), 2008, pp. 217-224.
13. P. Skums, et al., "Efficient error correction for deep sequencing of viral amplicons", Proc. 7th International Symposium on Bioinformatics Research and Applications (ISBRA 2011), Changsha, China, May 27-29, 2011, pp. 133-137.
14. C. Wilke, "Quasispecies theory in the context of population genetics", BMC Evolutionary Biology, 5: 44, 2005.